Lilly - March 2026 - case study 1

Start date:

Optimising Intravenous (IV) Infusion, Magnetic Resonance Imaging (MRI), and Outpatient Pathways for Alzheimer’s Disease (AD) Treatment

Last reviewed date: 30 April 2026

Next review date: 30 April 2029